Register Register Interest for the Neuropsychiatric Drug Development Summit Gain an important market update on the progress of neuropsychiatric drug development through pioneering clinical case studies across schizophrenia, SUD and treatment resistant depression Engage in critical discussions with industry experts and hear insights into novel electrophysiological biomarkers of synaptic plasticity in humans and how we can establish digital therapeutics as a meaningful new treatment category for patients Establish lasting connections with this dedicated community to accelerate your products to market and help patients in need REGISTER INTEREST